T

Theriva Biologics
D

TOVX

0.25750
USD
0.02
(7.07%)
مغلق
حجم التداول
46,237
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
8,687,958
الأخبار المقالات

العنوان: Theriva Biologics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.